PortfoliosLab logoPortfoliosLab logo
ISIN
US42217D1028
IPO Date
Dec 23, 2024

Highlights

Market Cap
$57.30M
Enterprise Value
$47.17M
EPS (TTM)
-$0.01
Total Revenue (TTM)
$34.08M
Gross Profit (TTM)
$20.09M
EBITDA (TTM)
-$403.81K
Year Range
$0.77 - $4.02
Target Price
$4.00
ROA (TTM)
-2.79%
ROE (TTM)
-3.74%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Health In Tech, Inc

Often compared with HIT:
HIT vs. NBISHIT vs. F

Performance

HIT Performance Chart

Health In Tech, Inc (HIT) is down 37.2% since the beginning of the year. At $1 per share, HIT is trading 75.1% below its 52-week high of $4.


Loading charts...

S&P 500 Index

Returns By Period

Health In Tech, Inc (HIT) has returned -37.17% so far this year and 50.86% over the past 12 months.


Health In Tech, Inc

1D
1.98%
1M
11.19%
YTD
-37.17%
6M
-31.58%
1Y
50.86%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-1.44%
1M
-1.45%
YTD
7.60%
6M
6.59%
1Y
22.24%
3Y*
19.20%
5Y*
11.54%
10Y*
13.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HIT Monthly Returns History

Based on dividend-adjusted daily data since Dec 23, 2024, HIT's average daily return is +0.05%, while the average monthly return is +3.92%. At this rate, an investment would double in approximately 1.5 years.

Historically, 63% of months were positive and 37% were negative. The best month was Jul 2025 with a return of +135.2%, while the worst month was Mar 2025 at -90.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 2 months.

On a daily basis, HIT closed higher 49% of trading days. The best single day was May 8, 2025 with a return of +28.0%, while the worst single day was Mar 12, 2025 at -82.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-27.04%21.55%2.84%0.00%-31.58%0.70%-37.17%
20253.08%27.72%-90.61%-8.27%0.41%44.38%135.23%32.85%16.73%-17.45%-42.64%4.61%-70.31%
20242.00%2.00%

Benchmark Metrics

Health In Tech, Inc has an annualized alpha of -5.66%, beta of 1.14, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since December 23, 2024.

  • This stock participated in 398.97% of S&P 500 Index downside but only 58.87% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-5.66%
Beta
1.14
0.02
Upside Capture
58.87%
Downside Capture
398.97%

Return for Risk

Risk / Return Rank

HIT ranks 60 for risk / return — better than 60% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


HIT Risk / Return Rank: 6060
Overall Rank
HIT Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
HIT Sortino Ratio Rank: 6666
Sortino Ratio Rank
HIT Omega Ratio Rank: 6464
Omega Ratio Rank
HIT Calmar Ratio Rank: 5858
Calmar Ratio Rank
HIT Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Health In Tech, Inc (HIT) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HITBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.35

Sortino ratioReturn per unit of downside risk

-0.96

Omega ratioGain probability vs. loss probability

1.18

1.32

-0.15

Calmar ratioReturn relative to maximum drawdown

0.66

2.46

-1.79

Martin ratioReturn relative to average drawdown

1.01

10.92

-9.91

Dividends

Dividend History


Health In Tech, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Health In Tech, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Health In Tech, Inc was 92.56%, occurring on Apr 7, 2025. The portfolio has not yet recovered.

The current Health In Tech, Inc drawdown is 86.61%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-92.56%Apr 2025
26d
1y 3moMar 2025 - now
2025 selloff2025
-17.15%Feb 2025
4d14d
18dJan 2025 - Feb 2025
2025 correction2025
-15.44%Jan 2025
1d7d
8dJan 2025 - Jan 2025
2025 pullback2025
-6.91%Jan 2025
11d8d
19dDec 2024 - Jan 2025
2025 selloff2025
-6.10%Mar 2025
0s1d
1dMar 2025 - Mar 2025

Drawdown Indicators


HITBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-92.56%

-56.78%

-35.78%

Max Drawdown (1Y)

Largest decline over 1 year

-77.02%

-9.10%

-67.92%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-86.61%

-3.21%

-83.40%

Average Drawdown

Average peak-to-trough decline

-68.55%

-10.71%

-57.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.63%

2.04%

+48.59%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Health In Tech, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Health In Tech, Inc is priced in the market compared to other companies in the Software - Application industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HIT relative to other companies in the Software - Application industry. Currently, HIT has a P/S ratio of 1.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HIT in comparison with other companies in the Software - Application industry. Currently, HIT has a P/B value of 2.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HIT

Add Health In Tech, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HIT